Prot #AXS02-301: CREATE-1 Study: CRPS Treatment Evaluation 1 Study: A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional

Project: Research project

Project Details

StatusFinished
Effective start/end date3/10/16 → 3/10/19

Funding

  • Axsome Therapeutics, Inc. (Prot #AXS02-301)